Skip to main content
. 2024 May 30;27(8):1555–1564. doi: 10.1038/s41593-024-01654-y

Fig. 5. Nf1 mutation inhibits OPC differentiation, and Nf1-mutant mice exhibit delayed oligodendroglial development.

Fig. 5

a,b, WT, Nf1+/− and Nf1−/− OPCs were cultured and induced for differentiation. Immunocytochemistry using MBP (oligodendrocyte marker) and Olig2 (oligodendroglial lineage marker) antibodies revealed a reduced percentage of oligodendrocytes (the number of MBP+ cells divided by the number of Olig2+ cells) in Nf1+/− and Nf1−/− OPCs, compared to the WT OPCs. Brown–Forsythe ANOVA test (F = 18.15) with Dunnett’s T3 multiple comparisons. *P = 0.0111; ***P = 0.0008. Scale bar, 50 µm. c, Immunohistochemistry performed in the cingulum of 1-month-old Nf1WT and Nf1OPC-iKO mice (tamoxifen injection at P28) revealed that Nf1OPC-iKO mice had reduced density of oligodendrocytes (Olig2+/PDGFRα cells). N = 4 per group. *P = 0.0382. d, Immunohistochemistry in the cingulum of 4-month-old Nf1WT (N = 7) and Nf1OPC-iKO (N = 5) mice revealed similar oligodendrocyte (ASPA+ cells) density. Unpaired t-test with Welch’s correction (c and d). Data shown as mean ± s.e.m.; each point represents one mouse (c and d); two-sided; NS, not significant (P > 0.05).

Source data